Literature DB >> 4292721

On the mode of action of 7-deaza-adenosine (tubercidin).

A Bloch, R J Leonard, C A Nichol.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4292721     DOI: 10.1016/0005-2787(67)90581-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  6 in total

1.  The action of inhibitors of nucleic acids synthesis on Euglena.

Authors:  L Ebringer
Journal:  Experientia       Date:  1971-05-15

2.  A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties.

Authors:  David B Olsen; Anne B Eldrup; Linda Bartholomew; Balkrishen Bhat; Michele R Bosserman; Alessandra Ceccacci; Lawrence F Colwell; John F Fay; Osvaldo A Flores; Krista L Getty; Jay A Grobler; Robert L LaFemina; Eric J Markel; Giovanni Migliaccio; Marija Prhavc; Mark W Stahlhut; Joanne E Tomassini; Malcolm MacCoss; Daria J Hazuda; Steven S Carroll
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

3.  Studies on the coronary dilator actions of some adenosine analogues.

Authors:  L B Cobbin; R Einstein; M H Maguire
Journal:  Br J Pharmacol       Date:  1974-01       Impact factor: 8.739

Review 4.  The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold.

Authors:  Katherine L Seley-Radtke; Mary K Yates
Journal:  Antiviral Res       Date:  2018-04-10       Impact factor: 10.103

Review 5.  The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold.

Authors:  Mary K Yates; Katherine L Seley-Radtke
Journal:  Antiviral Res       Date:  2018-12-08       Impact factor: 10.103

6.  Nearest-neighbor parameters for 7-deaza-adenosine·uridine base pairs in RNA duplexes.

Authors:  Katherine E Richardson; Brent M Znosko
Journal:  RNA       Date:  2016-04-20       Impact factor: 4.942

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.